Table 2. Median disease-free interval for all patients by prognostic factors.
Variables | No. of events/No. of patients | Disease-free interval* (months) |
p- value |
---|---|---|---|
All patients | 25/25 | 25.1 (12.8–35.2) | |
Cancer stage | |||
One | 7/7 | 33.7 (5.8–52.4) | 0.630 |
Two | 3/3 | 23.0 (9.8–undefined) | |
Three | 13/13 | 16.8 (10.7–33.6) | |
Tumor grade | |||
One | 5/5 | 63.2 (5.8–undefined) | 0.009 |
Two | 10/10 | 16.7 (8.0–38.0) | |
Three | 10/10 | 22.4 (5.4–26.6) | |
Histopathology | |||
Serous | 11/11 | 26.6 (10.7–46.2) | 0.705 |
Endometroid | 7/7 | 12.8 (8.0–51.4) | |
Clear cell | 5/5 | 25.1 (12.6–undefined) | |
Mucinous | 2/2 | 5.8 (5.8–undefined) | |
Primary cytoreduction | |||
Optimal | 20/20 | 25.1 (9.8–46.2) | 0.313 |
Suboptimal | 5/5 | 22.4 (10.7–undefined) |
**Median (95% CI).